Polyneuropathy, with and without neurogenic pain, and its impact on daily life activities – A descriptive study

References

• Asbury A K, Gilliat R W. The clinical approach to neuropathy. Peripheral nerve disorders, A K Asbury, R W Gilliat. Butterworths, Boston 1984; 1–20
   Google Scholar
• Lindh J, Tondel M, Österberg A, Vrethem M. Cryptogenic polyneuropathy: clinical and neurophysiological findings. J Peripher Nerv Syst 2005; 10: 31–37
   PubMed Web of Science ®Google Scholar
• Kelly J J, Jr, Kyle R A, O'Brien P C, Dyck P J. Prevalence of monoclonal protein in peripheral neuropathy. Neurology 1981; 31: 1480–1483
   PubMed Web of Science ®Google Scholar
• Notermans N C, Wokke J HJ, Franssen H, van der Graaf Y, Vermeulen M, van den Berg L H, Bär P R, Jennekens F GI. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 1993; 56: 1066–1071
   PubMed Web of Science ®Google Scholar
• Chan A W, MacFarlane I A, Bowsher D R, Wells J C, Bessex C, Griffiths K. Chronic pain in patients with diabetes mellitus: comparison with a nondiabetic population. Pain Clin 1990; 2: 147–159
   Google Scholar
• Italian General Practitioner Study Group. Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample, 1995. Neurology 1995; 45: 1832–1836
   PubMed Web of Science ®Google Scholar
• MacDonald B K, Cockerell O C, Sander J W, Shorvon S D. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000; 123: 665–676
   PubMed Web of Science ®Google Scholar
• Molenaar D S, de Haan R, Vermeulen M. Impairment, disability, or handicap in peripheral neuropathy: analysis of the use of outcome measures in clinical trials in patients with peripheral neuropathies. Neurol Neurosurg Psychiatry 1995; 59: 165–169
   PubMed Web of Science ®Google Scholar
• Cohen K L, Harris S. Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch Intern Med 1987; 147: 1442–1444
   PubMed Web of Science ®Google Scholar
• van Doorn P A, Brand A, Strengers P FW, Meulstee J, Vermeulen M. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology 1990; 40: 209–212
   PubMed Web of Science ®Google Scholar
• Vermeulen M, van Doorn P A, Brand A, Strengrs P FW, Jennekens F GI, Busch H FM. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1993; 56: 36–39
   PubMed Web of Science ®Google Scholar
• Capsaicin Study Group. Effect of treatment with Capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 1992; 15: 159–165
   PubMed Web of Science ®Google Scholar
• Bowling A. What things are important in people's lives? A survey of the public's judgements to inform scales of health-related quality of life. Soc Sci Med 1995; 41: 1447–1462
   PubMed Web of Science ®Google Scholar
• Teunissen L L, Eurelings M, Notermans N C, Hop J W, van Gijn J. Quality of life in patients with axonal polyneuropathy. J Neurol 2000; 247: 195–199
   PubMed Web of Science ®Google Scholar
• Burckhardt C S, Archenholtz B, Bjelle A. Measuring the quality of life of women with Rheumatoid Arthrithis or systemic Lupus Erythematosus: a Swedish version of the Quality of Life Scale (QOLS). Scand J Rheumatol 1992; 21: 190–195
   PubMed Web of Science ®Google Scholar
• Flanagan J C. A research approach to improving our quality of life. Am Psych 1978; 138–147
   Web of Science ®Google Scholar
• Flanagan J C. Measurement of quality of life: current sate of the art. Arch Phys Med Rehabil 1982; 63: 56–59
   PubMed Web of Science ®Google Scholar
• Burckhardt C S, Woods S L, Schultz A A, Ziebarth D M. Quality of life of adults with chronic illness: a psychometric study. Res Nurs Health 1989; 12: 347–354
   PubMed Web of Science ®Google Scholar
• Wahl A, Burckhardt C S, Wiklund I, Rokne Hanestad B. The Norwegian version of the Quality of Life Scale (QOLS-N). Scand J Caring Sci 1998; 12: 215–222
   PubMed Web of Science ®Google Scholar
• Liedberg G M, Burckhardt C S, Henriksson C M. Validity and reliability testing of the Quality of Life Scale, Swedish version in women with fibromyalgia – statistical analyses. Scand J Caring Sci 2005; 19: 64–70
   PubMed Web of Science ®Google Scholar
• Burckhardt C S, Anderson K L. The Quality of Life Scale (QOLS): reliability, validity, and utilization. Health Qual Life Outcomes 2003; 1: 60, Available from http://www.hqlo.com/content/1/1/60
   PubMedGoogle Scholar
• Burckhardt C S, Anderson K L, Archenholtz B, Hägg O. The Flanagan Quality of Life Scale: evidence of construct validity. Health Qual Life Outcomes 2003; 1: 59, Available from http://www.hqlo.com/content/1/1/59
   PubMedGoogle Scholar
• Abresch R T, Carter G T, Jensen M P, Kilmer D D. Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hospice Palliative Care 2002; 19: 39–48
   PubMedGoogle Scholar
• Vrethem M, Boivie J, Arnqvist H, Holmgren H, Lindström T. Painful polyneuropathy in patients with and without diabetes: clinical, neurophysiologic, and quantitative sensory characteristics. Clin J Pain 2002; 18: 122–127
   PubMed Web of Science ®Google Scholar
• Hughes R AC, Umapathi T, Gray I A, Gregson N A, Noori M, Pannala A S, Preteggente A, Swan A V. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain 2004; 127: 1723–1730
   PubMed Web of Science ®Google Scholar
• Schlenk E A, Erlen J A, Dunbar-Jacob J, McDowell J, Engberg S, Sereika S M, Rohay J M, Bernier M J. Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36. Qual Life Res 1998; 7: 57–65
   PubMed Web of Science ®Google Scholar
• Birkholz M, Aylwin L, Harman R M. Activity pacing in chronic pain management: One aim, but which method? Part 1: Introduction and literature review. Br J Occup Ther 2004; 67: 447–452
   Google Scholar
• Birkholz M, Aylwin L, Harman R M. Activity pacing in chronic pain management: One aim, but which method? Part 2: National activity pacing surbey. Br J Occup Ther 2004; 67: 481–487
   Google Scholar
• Daltroy L H, Larson M G, Holley M E, Phillips C B, Liang M H. Discrepancies between self-reported and observed physical function in the elderly: the influence of response shift and other factors. Soc Sci Med 1999; 48: 1549–1561
   PubMed Web of Science ®Google Scholar
• Dyck P J, O'Brien P C. Polyneuropathy dysfunction scores. Editorial commentary. Downloaded from jnnp.bmjjournals.com. 30 oct, 2006
   Google Scholar